Cleerly has launched Cleerly Preview, a new workflow-support feature designed to assist clinicians with case prioritization and streamline administrative processes, such as prior authorization, for coronary artery disease imaging.
The feature is an enhancement to the company’s AI-enabled quantitative computed tomography (AI-QCT) platform for coronary artery disease imaging. Specifically, the update adds greatest-diameter stenosis values and stenosis location information to the platform, with stenosis ranges mapped to established reimbursement thresholds to facilitate prior authorization, according to the company.
Cleerly will unveil the tool at the American College of Cardiology annual meeting being held March 28 to March 30 in New Orleans.
